DCM
PGNX

Driehaus Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Driehaus Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-21,323
Closed -$201K – 681
2017
Q1 		$201K Buy
+21,323
New +$201K 0.01% 513